Another day, another potential Tadawul listing: Dr Soliman Abdul KaderFakeeh Hospital (DSFH) has received Capital Market Authority approval to sell a 21.4% stake on Tadawul’s main market, the regulator said in a statement yesterday. The CMA provided no further details other than to offer its standard note that the hospital company’s prospectus would be published “within sufficient time prior to the start of the subscription period.”

About the DSFH: Founded in Jeddah in 1978 by Dr Soliman Fakeeh, DSFH has emerged as a leading private healthcare provider in the Kingdom. It is a regional healthcare player in organ transplants and open-heart surgeries and treats some 500k patients each year.

Healthcare operators have been lining up to IPO: Al Hammadi (2015) and Saudi German Healthcare (2016) led the way, with Dr Sulaiman Al Habib, pharma group Al Nahdi Medical, and drugmakers Jamjoom Pharma and Avalon Pharma all having followed suit. Aster DM Healthcare, meanwhile, is said to be looking to spin off its GCC unit with a dual listing on Tadawul and the Dubai Financial Market.

Background: DSFH operator Fakeeh Care had been mulling a share sale since last year,. sources told Reuters at the time.

REMEMBER- The domestic IPO market is still going strong in 1Q 2024 with regional broadcaster MBC debuting on Tadawul in January in a USD 222 IPO. Modern Mills made its market debut last week. Avalon Pharma also went public on the main market. Al Modawat Specialized Medical Hospital and Pan Gulf Marketing have both made their debuts on Nomu.

Tags: